Tue, January 3, 2012
Mon, January 2, 2012
Sat, December 31, 2011
Fri, December 30, 2011
Thu, December 29, 2011
Wed, December 28, 2011
Tue, December 27, 2011
Mon, December 26, 2011
Fri, December 23, 2011
Thu, December 22, 2011
Wed, December 21, 2011
Tue, December 20, 2011
Mon, December 19, 2011
Sun, December 18, 2011
Sat, December 17, 2011
Fri, December 16, 2011
Thu, December 15, 2011

Valeant Pharmaceuticals Completes Acquisition of iNova

  Copy link into your clipboard //health-fitness.news-articles.net/content/2011/ .. rmaceuticals-completes-acquisition-of-inova.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

Valeant Pharmaceuticals Completes Acquisition of iNova -- MISSISSAUGA, Ontario, Dec. 22, 2011 /PRNewswire/ --

Valeant Pharmaceuticals Completes Acquisition of iNova

[ ]

MISSISSAUGA, Ontario, Dec. 22, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: [ VRX ] and TSX: VRX) announced that effective December 21, 2011, the company completed its previously announced acquisition of iNova, from Archer Capital, Ironbridge and other minority management shareholders.

BofA Merrill Lynch and Baker & McKenzie acted as Valeant's advisors in connection with this transaction.

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant Pharmaceuticals International, Inc. can be found at [ www.valeant.com ].

(Logo: [ http://photos.prnewswire.com/prnh/20101025/LA87217LOGO ])

Contact Information:
Laurie W. Little
949-461-6002
[ laurie.little@valeant.com ]     

SOURCE Valeant Pharmaceuticals International, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.valeant.com ]